Search - tctmd.com

Displaying 1 - 20 of 157

Sort: Relevancy | Date

News Conference News STS 2026

Industry Pays Far Less in Royalties, Consulting Fees to Female vs Male Surgeons

Yael L. Maxwell

February 09, 2026

News Daily News

Andexanet Alfa Pulled From US Market

Todd Neale

December 22, 2025

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Daily News

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Michael O'Riordan

March 11, 2025

News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

L.A. McKeown

January 31, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Daily News

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Yael L. Maxwell

August 16, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

COVID-19 Vaccination Tied to Fewer CV Events in Large UK Study

Todd Neale

August 01, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Daily News

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

L.A. McKeown

February 23, 2024

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

News Daily News

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

L.A. McKeown

August 31, 2023

News Daily News

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

Shelley Wood

May 30, 2023

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

L.A. McKeown

May 22, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

Advertisement

Industry Pays Far Less in Royalties, Consulting Fees to Female vs Male Surgeons

Andexanet Alfa Pulled From US Market

What’s Going to Be Hot at ESC Congress 2025?

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

What’s Going to Be Hot at ACC 2025?

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

COVID-19 Vaccination Tied to Fewer CV Events in Large UK Study

What’s Going to Be Hot at ACC 2024

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

Top Coronary Artery Disease News of 2023

What’s Going to Be Hot at AHA 2023

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content